Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Nonmyeloablative Allogeneic Stem Cell Transplantation For Relapsed Hodgkin's or Non-Hodgkin's Lymphoma After Autologous Transplantation ( A BMT Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00121186
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:20.752273+00:00
Published At
2012-04-03T00:00:00+00:00
Record Updated At
2012-04-03
Results Posted At
2012-04-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2012-04-03"
protocolSection.identificationModule.nctId
"NCT00121186"
protocolSection.identificationModule.officialTitle
"Nonmyeloablative Allogeneic Stem Cell Transplantation For Relapsed Hodgkin\u0027s or Non-Hodgkin\u0027s Lymphoma After Autologous Transplantation ( A BMT Study)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2012-04-03"

Study condition terms

  • Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.